Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

Tako-tsubo Cardiomyopathy: A Heart Stressed out of Energy?

MPG-Autoren
/persons/resource/persons84402

Henning,  A
Research Group MR Spectroscopy and Ultra-High Field Methodology, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte in PuRe verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Dawson, D., Neil, C., Henning, A., Cameron, D., Jagpal, B., Bruce, M., et al. (2015). Tako-tsubo Cardiomyopathy: A Heart Stressed out of Energy? JACC: Cardiovascular Imaging, 8(8), 985-987. doi:10.1016/j.jcmg.2014.10.004.


Zitierlink: https://hdl.handle.net/11858/00-001M-0000-002A-44FA-9
Zusammenfassung
Tako-tsubo cardiomyopathy (TTC) is an acute form of left ventricular (LV) systolic dysfunction often following intense stress, but its pathophysiology remains elusive. Because of its reversible natural course without much apparent myocyte damage, as inferred by the lack of late gadolinium-enhanced (LGE) cardiac magnetic resonance (CMR), it has been a priori assumed that its evolution is benign (1). Whatever the etiology of the acute insult, it is important to establish the nature of this state of intense myocardial contractile dysfunction with preserved viability, as this may point to a potential therapeutic target in those cases with a less favorable clinical course. It is known that impaired cardiac energetic status is directly linked to clinical and subclinical LV dysfunction. We hypothesized that impaired cardiac energetics may occur in acute TTC, further investigating its recovery at 4 months follow-up. We prospectively recruited 26 patients with a clear-cut diagnosis of TTC (2) and 11 matched healthy controls; all provided informed consent. Patients underwent 31P-CMR spectroscopy (31P-CMRS) (3) and imaging (inclusive of native T1 mapping with a 3(3)3(3)5 scheme) on a 3-T Philips scanner (Best, the Netherlands), short term (days 0 to 3) and at 4 months follow-up. 31P-CMRS was analyzed with JMRUi-3 (University of Lyon, Lyon, France), LV volumes/mass with CMRTools (Cardiovascular Imaging Solutions, London, United Kingdom), wall motion scored (1 = normal, 2 = hypokinetic, 3 = akinetic, 4 = dyskinetic) and T1 maps generated with RelaxMaps (Philips)/Segment (Medviso, Lund, Sweden). C-reactive protein (CRP) and troponin I were recorded on admission. Follow-up 31P-CMRS and imaging were achieved in 20 patients (3 device implantations, 2 in-hospital deaths, 1 claustrophobia were excluded). Data are shown as mean ± SD unless otherwise stated. Comparisons between groups were performed using independent/paired Student t tests with significance at p < 0.05. The patients’ mean age was 63 years (range 41 to 87 years), and 92 were women. The majority presented with chest pain (80) and had a stressful trigger (73), widespread ST-segment elevation electrocardiogram (70), and apical ballooning variant (77). The 12-h troponin level was 3.45 ng/ml (range 0.22 to 11.97 ng/ml), and CRP was 21.5 (range <4 to 75). Mean LV ejection fraction was reduced and LV mass index increased during the acute study versus healthy controls (54 ± 12 vs. 66 ± 4 and 77 ± 15 g/m2 vs. 66 ± 10 g/m2, respectively, p < 0.05 for both); all normalized at follow-up. LGE was present in only 4 cases, as a transmural band at the hinge points of the wall motion abnormality in 3 cases and as nonconfluent small foci in another case. A significant increase in native whole myocardium T1 relaxation time was seen during the acute presentation compared with healthy volunteers (1,253 ± 63 ms vs. 1,188 ± 16 ms, p = 0.004), and this improved significantly (1,196 ± 29 ms) at follow-up (p = 0.01) (Figure 1A). The acute changes were driven by both the T1 values measured from acutely dysfunctional segments (T1 = 1,279 ± 86 ms, p = 0.03 vs. healthy controls) but also by the segments with normal wall motion in the acute study (1,226 ± 49 ms, p = 0.02 vs. healthy controls). At follow-up, the T1 relaxation times significantly improved (1,177 ± 42 ms) compared with the acute study in the nondysfunctional segments (p = 0.008), but this improvement only showed a trend in the previously dysfunctional myocardium (p = 0.05), which remained significantly abnormal compared with healthy controls (T1 = 1,224 ± 40 ms, p = 0.013 vs. healthy controls), implying that a certain degree of myocardial edema remains present until at least this stage.